Clinicopathological variables used at present for prognostication and treatment selection for
papillary thyroid carcinomas (PTCs) do not uniformly predict tumor behavior, necessitating …

This study addressed the immunohistochemical expression of MUC1 in papillary thyroid
carcinoma (PTC) of different histotypes, sizes, and morphological features of …

Our purpose was to evaluate MUC1 clinical utility in the diagnosis and prognosis of thyroid
cancer patients. We studied the protein expression of MUC1 in 289 thyroid carcinomas and …

Purpose We have previously conducted independent microarray expression analyses of the
two most common types of nonmedullary thyroid carcinoma, namely papillary thyroid …

BACKGROUND: We recently identified MUC1 as a target driving selection for 1q21
amplification and validated it as an independent marker of aggressive behavior in thyroid …

Background: Papillary thyroid carcinoma (PTC) is the most frequent carcinoma of the thyroid
gland and has a relatively good prognosis. However, it is important to identify PTC …

The purpose of this paper is to correlate the molecular phenotype of papillary thyroid
carcinoma (PTC) to their biological pathology. We hybridized 26 PTC on microarrays and …

Abstract Background The incidence of Papillary thyroid carcinoma (PTC), the most common
type of thyroid malignancy, has risen rapidly worldwide. PTC usually has an excellent …

Overexpression of MUC1 oncoprotein is frequently observed in cancer and contributes to
confer resistance to genotoxic agents. Papillary, follicular, and anaplastic thyroid carcinomas …

Improvement in the clinical outcome of human cancers requires characterization of the
genetic alterations underlying their pathogenesis. Large‐scale genomic and transcriptomic …